Clinical Trial Update: Early and Late Neutrophil CD64 and Monocyte HLA-DR as Biomarkers for Septic Shock

View source ↗

Summary

The clinical trial evaluating early and late neutrophil CD64 and monocyte HLA-DR as biomarkers for septic shock has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Snippet

Sponsor: Pandit Bhagwat Dayal Sharma, PGIMS, Rohtak | Conditions: Sepsis, Septic Shock | Status: COMPLETED